Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Study Design: Treatment, Single Group Assignment (7 cohorts), Open Label, Non-Randomized, Safety Study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients wtih adenocarcinoma of the colon or rectum)
Eastern Cooperative Oncology Group (ECOG) 0 or 1
You may not be if
Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens
Prior treatment with more than 2 cycles of carboplating-based chemotherapy regimens
For colorectal cancer patients in the expanded cohorts, prior treatment with more than 2 systemic chemotherapy regimens in the metastatic setting
